Diana E. Lake, MD

Diana E. Lake, MD

Medical Oncologist

Clinical Expertise

Breast Cancer

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Lake accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me


MD, Chicago Medical School


Pathology - New York Hospital/Cornell University Medical College; Internal Medicine - North Shore University Hospital


Hematology/Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Medical Oncology; Hematology

I am a medical oncologist with a practice that is devoted solely to the care of people with breast cancer. My research interests involve all areas of breast cancer but focus mainly on the development of new therapies, prevention of cancer recurrence following surgery, and treatment of recurrent disease. Working in conjunction with my colleagues on the Breast Medicine Service, and in breast, surgical, and radiation, and as the liaison in breast medicine to Cancer and Leukemia Group B (a national clinical trial cooperative research group sponsored by the National Cancer Institute), I am involved in clinical trials to develop better hormonal therapies and improved approaches to treatment before surgery. In addition, I am a member of the National Institutes of Health (NIH) Scientific Review Committee, and I previously served on the NIH Cooperative Group Review and its Cancer Education committees.


Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. I work closely with nurse practitioner Danielle Alleva. We combine our expertise to provide comprehensive care to our patients at every step of their cancer journey.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Dawson N, Lake D, et al. A randomized study comparing standard vs. moderately high dose megace acetate in prostate cancer. CALGB Study 9181. Cancer 2000; 88: 825-34.

Easaw S, Lake DE, Beer M, Seiter K, Feldman E, Ahmed T. Graft-Versus-Host Disease: Possible Higher Risk for African-American Patients. Cancer 1996; 78: 1492-1497.

Lake DE, Kunzweiler J, Beer M, Buell DN, Islam MZ. Fluconazole versus Amphotericin B in the Treatment of Esophageal Candidiasis in Cancer Patients. Chemotherapy 1996; 42: 308-314.

Marchalonis JJ, Schluter SF, Wang E, Dehhanpisheh K, Lake D, Yocum DE, Edmnundson AB, Windfield JB. Synthetic autoantigens of immunoglobulins and t-cell receptors: Their recognition in aging, infection, and autoimmunity. Pro Soc Exper Bio Med 1994; 207: 129-47.

Goldenberg D, Sharkey R, Hall T, Mortly S, Siegel, Izon D, Swayne C, Lake D, Hansen H, Pinsky C. Radio-immunotherapy of B-Cell lymphomas with 131-I-labeled L12 (EPB-2) monoclonal antibody. Antibody Immunoconjugate Radio-pharmaceuticals 1991; 4: 763-769.

Alzarka A, Haft J, Bassil H, Goldstein J, Arkel Y, Lake-Lewin D. Correlation of cross-linked fibrin degradation products (D-Dimers) with coronary angiographic lesion morphology. Int J Cardiol 1991; 30:77.

Kris MG, Pablo D, Gralla RJ, Burke T, Prestifilippo J, Lake-Lewin D. Pulmonary toxicity following vinblastine administration in patients receiving mitocycin plus vinca alkaloid combination therapy. Cancer Treat Reports 68, 1019-1031.

Yen A, Lake-Lewin D. Uncoupling lymphocyte proliferation from differentiation:dissimilar dose response relations pokeweek mitogen induced proliferation and differentiation of normal human lymphocytes. Cellular Immunol 1981; 61: 332, 1981.

Lake-Lewin D, Meyers J, Lee B, Young C. Phase III study of lyrazofurin (PZF) in the treatment of multiple myeloma refractory to standard cytotoxic therapy. Cancer Treat Reports. 1979; 63:1403.

Lake-Lewin D, Schulman P. An unusual case of extramedullary myeloma with metastatic features. JAMA 1979; 242:65.


Publications on PubMed

Visit PubMed for a full listing of Dr. Lake’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.